Unichem Lab share price has zoomed 5% and is presently trading at Rs 796.8.
Meanwhile, the BSE HEALTHCARE index is at 43,664.8 (down 0.4%).
Among the top gainers in the BSE HEALTHCARE index today are POLY MEDICURE (up 1.3%) and CAPLIN POINT (up 1.1%).
Jubilant Pharmova (down 2.8%) and Pfizer (down 2.2%) are among the top losers today.
Over the last one year, Unichem Lab has moved up from Rs 421.8 to Rs 796.8, registering a gain of Rs 375.0 (up 88.9%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,328.3 to 43,664.8, registering a gain of 54.1% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 180.8%), SUVEN PHARMACEUTICALS (up 117.5%) and Glenmark Pharma (up 115.0%).
Don't Miss: Key Information for Long-term Investors
The BSE Sensex is at 81,013.0 (down 0.2%).
The top losers among the BSE Sensex today are Tata Motors (down 1.9%) and Tata Steel (down 1.8%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,713.8 (down 0.3%). Tata Motors and Maruti Suzuki are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,877.0 to 81,013.0, registering a gain of 15,136.0 points (up 23.0%).
Unichem Lab net profit grew 1485.5% YoY to Rs 93 million for the quarter ended June 2024, compared to a loss of Rs 7 million a year ago. Net sales rose 5.5% to Rs 4,464 million during the period as against Rs 4,232 million in April-June 2023.
For the year ended March 2024, Unichem Lab reported 65.2% increase in net profit to Rs -705 million compared to net loss of Rs 2,022 million during FY23. Revenue of the company grew 26.9% to Rs 17,049 million during FY24.
The current Price to earnings ratio of Unichem Lab, based on rolling 12 month earnings, stands at -92.6.
Equitymaster requests your view! Post a comment on "Unichem Lab Gains 5%; BSE HEALTHCARE Index Down 0.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!